ABL Diagnostics Logo

ABL Diagnostics

ABLD | PA

Overview

Corporate Details

ISIN(s):
FR0000063034 (+1 more)
LEI:
9695002UO0UHM0VKRH38
Country:
France
Address:
72 ROUTE DE THIONVILLE, 57140 WOIPPY
Sector:
Health Care
Industry:
Health Care Technology

Description

Advanced Biological Laboratories (ABL), S.A., is a diagnostic and medical software company founded in 2000 as a spin-off from CRP-Santé (https://www.lih.lu/) Luxembourg. ABL’s products offer to infectious disease clinicians, virology and microbiology laboratories. Assays and standalone software systems for accredited laboratories (i.e. ISO 15189), mainly for microbiology applications (related to HIV, SARS-CoV-2, Tuberculosis, HCV, HBV, HPV, CMV, HPV, Flu, 16s RNA…) for clinical genotyping through sequencing (DeepChek®), DNA and RNA detection and quantification (UltraGene®), including powerful downstream analysis software applications fully integrated with knowledge databases and analysis systems for capillary and high-throughput Next Generation Sequencing data. Clinical software applications for infectious diseases units IT dashboards and clinical database aggregation applications for research and clinical management

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-25 18:13
Transaction in Own Shares
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de r…
French 128.9 KB
2025-05-07 18:40
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 4.5 MB
2025-05-06 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 186.6 KB
2025-05-06 17:26
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 4.5 MB
2024-11-18 18:16
Interim Report
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise …
French 139.5 KB
2024-11-18 18:15
Interim Report
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French 1.8 MB
2024-08-30 18:00
General Meeting Notice
Modalités de mise à disposition des documents préparatoires à l'AG
French 237.1 KB
2024-08-26 14:30
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-08-05 18:00
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 197.7 KB
2024-07-31 22:36
Report Publication Announcement
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French 144.2 KB
2024-07-31 21:38
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-07-31 21:38
Annual Report (ESEF)
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-07-03 18:00
Capital/Financing Update
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
French 234.8 KB
2024-07-01 18:00
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 216.8 KB
2024-05-29 18:44
Report Publication Announcement
Informations privilégiées / Communiqué sur comptes, résultats
French 116.5 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Diagonal Bio AB Logo Diagonal Bio AB Sweden DIABIO
EDX Medical Group Plc United Kingdom N/A
Elekta Logo Elekta Sweden EKTA
Elos Medtech Logo Elos Medtech Sweden ELOS
Episurf Logo Episurf Sweden EPIS
FluoGuide A/S Logo FluoGuide A/S Denmark FLUO
GELION PLC Logo GELION PLC United Kingdom GELN
Genetic Analysis AS Logo Genetic Analysis AS Norway GEAN
Genomed Spolka Akcyjna Logo Genomed Spolka Akcyjna Poland GEN
Genomtec S.A. Logo Genomtec S.A. Poland GMT